Pilar Herrera

1.3k total citations
18 papers, 335 citations indexed

About

Pilar Herrera is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Pilar Herrera has authored 18 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 5 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Pilar Herrera's work include Acute Myeloid Leukemia Research (6 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Pilar Herrera is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Chronic Myeloid Leukemia Treatments (5 papers). Pilar Herrera collaborates with scholars based in Spain, Chile and Argentina. Pilar Herrera's co-authors include Javier López‐Jiménez, Fernando Martín‐Moro, Irene García, Jesús Fortün, Carlota García‐Hoz, Magdalena Corona, Carlos Jiménez, Adolfo Sáez, Juan Marquet and Miguel Piris‐Villaespesa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Frontiers in Immunology.

In The Last Decade

Pilar Herrera

17 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pilar Herrera Spain 10 171 141 79 76 69 18 335
Péter Reményi Hungary 13 228 1.3× 89 0.6× 44 0.6× 64 0.8× 135 2.0× 44 400
Radwan Massoud Lebanon 12 245 1.4× 158 1.1× 58 0.7× 88 1.2× 52 0.8× 51 397
Bader Alahmari Saudi Arabia 8 209 1.2× 75 0.5× 41 0.5× 110 1.4× 107 1.6× 38 343
Xinan Cen China 9 230 1.3× 155 1.1× 97 1.2× 165 2.2× 37 0.5× 61 406
Mohamed Samra Egypt 10 109 0.6× 84 0.6× 25 0.3× 45 0.6× 53 0.8× 44 296
Muthalagu Ramanathan United States 11 243 1.4× 103 0.7× 25 0.3× 102 1.3× 41 0.6× 53 390
Rayaz Ahmed India 12 286 1.7× 104 0.7× 50 0.6× 56 0.7× 105 1.5× 55 459
Miguel Piris‐Villaespesa Spain 10 43 0.3× 123 0.9× 105 1.3× 80 1.1× 60 0.9× 24 325
Yoshinari Kawabata Japan 9 182 1.1× 129 0.9× 74 0.9× 196 2.6× 36 0.5× 19 415
Bachar Samra United States 9 150 0.9× 136 1.0× 39 0.5× 52 0.7× 38 0.6× 18 364

Countries citing papers authored by Pilar Herrera

Since Specialization
Citations

This map shows the geographic impact of Pilar Herrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pilar Herrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pilar Herrera more than expected).

Fields of papers citing papers by Pilar Herrera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pilar Herrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pilar Herrera. The network helps show where Pilar Herrera may publish in the future.

Co-authorship network of co-authors of Pilar Herrera

This figure shows the co-authorship network connecting the top 25 collaborators of Pilar Herrera. A scholar is included among the top collaborators of Pilar Herrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pilar Herrera. Pilar Herrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Caballero‐Velázquez, Teresa, Pilar Herrera, Francesca Patriarca, et al.. (2022). Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment. Transplantation and Cellular Therapy. 28(5). 258.e1–258.e8. 6 indexed citations
2.
Bailén, Rebeca, José L. Vicário, Laura Solán, et al.. (2021). Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant. Frontiers in Immunology. 12. 674658–674658. 14 indexed citations
3.
Martín‐Moro, Fernando, Juan Marquet, Miguel Piris‐Villaespesa, et al.. (2020). Survival study of hospitalised patients with concurrent COVID‐19 and haematological malignancies. British Journal of Haematology. 190(1). e16–e20. 96 indexed citations
4.
Martínez‐Cuadrón, David, Eva Barragán, Pilar Martínez‐Sánchez, et al.. (2020). Improving the prediction of acute myeloid leukaemia outcomes by complementing mutational profiling with ex vivo chemosensitivity. British Journal of Haematology. 189(4). 672–683. 7 indexed citations
5.
García‐Gutiérrez, Valentín, A. M. Jiménez, María Jesús Blanchard, et al.. (2019). Validation of Daraex to Resolve Daratumumab-Induced Interferences in Pre-Transfusion Screen Tests. Blood. 134(Supplement_1). 4983–4983. 1 indexed citations
6.
Rubio, Montserrat López, et al.. (2018). A Case of Myeloproliferative Neoplasm with BCR-FGFR1 Rearrangement: Favorable Outcome after Haploidentical Allogeneic Transplantation. SHILAP Revista de lepidopterología. 2018. 1–4. 6 indexed citations
7.
Gayoso, Jorge, Pascual Balsalobre, María‐Jesús Pascual, et al.. (2016). Busulfan-based reduced intensity conditioning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience. Bone Marrow Transplantation. 51(10). 1307–1312. 20 indexed citations
8.
9.
10.
Sanz, Miguel Á., Pau Montesinos, Joaquı́n Dı́az-Mediavilla, et al.. (2015). Maternal and fetal outcomes in pregnant women with acute promyelocytic leukemia. Annals of Hematology. 94(8). 1357–1361. 11 indexed citations
11.
Martínez‐Cuadrón, David, Pau Montesinos, Albert Oriol, et al.. (2013). Phase II trial to assess the safety and efficacy of clofarabine in combination with low-dose cytarabine in elderly patients with acute myeloid leukemia. Annals of Hematology. 93(1). 43–46. 10 indexed citations
12.
13.
García‐Gutiérrez, Valentín, et al.. (2011). Impact of Second-Generation Tyrosine Kinase Inhibitors As Second Line Treatment for Patients with Chronic Myeloid Leukemia,. Blood. 118(21). 3780–3780. 12 indexed citations
14.
Insunza, A., J. Carrillo, M. Yamamoto, et al.. (2007). P26.03: Persistent fetal tachycardia and decelerations after abrupt stomach extrusion in gastroschisis. Ultrasound in Obstetrics and Gynecology. 30(4). 547–547. 1 indexed citations
15.
Arana-Trejo, Rosa Marı́a, et al.. (2002). BCR/ABLp210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML). Clinical & Laboratory Haematology. 24(3). 145–150. 44 indexed citations
16.
Villalón, Lucı́a, J Odriozola, J García Laraña, et al.. (2000). Autologous peripheral blood progenitor cell transplantation with <2×106 CD34+/kg: an analysis of variables concerning mobilisation and engraftment. The Hematology Journal. 1(6). 374–381. 25 indexed citations
17.
Villalón, Lucı́a, J Odriozola, J García Laraña, et al.. (2000). Autologous peripheral blood progenitor cell transplantation with <2 x 10(6) CD34(+)/kg: an analysis of variables concerning mobilisation and engraftment.. PubMed. 1(6). 374–81. 34 indexed citations
18.
Escribano, L., Jesús F. San Miguel, Pilar Bravo, et al.. (1999). Expression of Bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia. American Journal of Hematology. 60(3). 191–195. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Péter Reményi Breakdown of academic impact, for papers by Radwan Massoud Breakdown of academic impact, for papers by Bader Alahmari Breakdown of academic impact, for papers by Xinan Cen Breakdown of academic impact, for papers by Mohamed Samra Breakdown of academic impact, for papers by Muthalagu Ramanathan Breakdown of academic impact, for papers by Rayaz Ahmed Breakdown of academic impact, for papers by Miguel Piris‐Villaespesa Breakdown of academic impact, for papers by Yoshinari Kawabata Breakdown of academic impact, for papers by Bachar Samra
Rankless by CCL
2026